| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |